Citation Impact
Citing Papers
Advanced Atherosclerotic Foam Cell Formation Has Features of an Acquired Lysosomal Storage Disorder
2006
Altered properties of high density lipoprotein subfractions in obese subjects
1997
Identification of the Interaction Site within Acyl-CoA:Cholesterol Acyltransferase 2 for the Isoform-specific Inhibitor Pyripyropene A
2008 StandoutNobel
Cell cholesterol efflux: integration of old and new observations provides new insights
1999
Cytokines present in smokers' serum interact with smoke components to enhance endothelial dysfunction
2011
Atheroprotective mechanisms of HDL
1999
3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitors Attenuate β-Amyloid-Induced Microglial Inflammatory Responses
2005
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease
2006
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
2006 Standout
Recent advances in atherosclerosis-based proteomics: new biomarkers and a future perspective
2008
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases
2009
Effects of Torcetrapib in Patients at High Risk for Coronary Events
2007 Standout
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Antibiotic Treatment ofChlamydia pneumoniaeafter Acute Coronary Syndrome
2005 Standout
Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women
2007 Standout
Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo
2007
The metabolic syndrome
2006
Abnormal cholesterol metabolism in imipramine-treated fibroblast cultures. Similarities with Niemann-Pick type C disease
1990
Hallmarks of aging: An expanding universe
2023 Standout
Macrophages in the Pathogenesis of Atherosclerosis
2011 Standout
The toxicity to macrophages of oxidized low-density lipoprotein is mediated through lysosomal damage
1997
C-Reactive Protein Levels and Outcomes after Statin Therapy
2005 Standout
Interaction between high-density lipoproteins and inflammation: Function matters more than concentration!
2020
Apolipoprotein A-IMilano: current perspectives
2003
Abdominal aortic aneurysm
2005 Standout
Reduction of Isoprostanes and Regression of Advanced Atherosclerosis by Apolipoprotein E
2001
Effect of Statin Therapy on C-Reactive Protein Levels
2001
The changing landscape of atherosclerosis
2021 StandoutNature
Trans Fatty Acids and Cardiovascular Disease
2006 Standout
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
2002 Standout
Functional Lecithin: Cholesterol Acyltransferase Is Not Required for Efficient Atheroprotection in Humans
2009
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
2007 StandoutNature
Statin effects beyond lipid lowering—are they clinically relevant?
2003
Apop-1, a Novel Protein Inducing Cyclophilin D-dependent but Bax/Bak-related Channel-independent Apoptosis
2006 StandoutNobel
Ebola virus entry requires the cholesterol transporter Niemann–Pick C1
2011 StandoutNature
Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary Syndromes<SUBTITLE>The MIRACL Study: A Randomized Controlled Trial</SUBTITLE>
2001 Standout
Sphingomyelinase, an Enzyme Implicated in Atherogenesis, Is Present in Atherosclerotic Lesions and Binds to Specific Components of the Subendothelial Extracellular Matrix
1999
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
The Antiphospholipid Syndrome
2002 Standout
3 ACAT Inhibitors: The Search for a Novel and Effective Treatment of Hypercholesterolemia and Atherosclerosis
2002
HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients
2002
Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willebrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease
2002
High-density lipoprotein heterogeneity and function in reverse cholesterol transport
2010
NAD+ homeostasis in health and disease
2020
Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: The pathogenic and diagnostic implications
2001
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardiovascular risk
2004
Estrogen plus Progestin and the Risk of Coronary Heart Disease
2003 Standout
Alzheimer's Disease
2010 Standout
Inflammation in atherosclerosis
2002 StandoutNature
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
Angiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft Rejection
2005 Standout
Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis
2004 Standout
Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia
2000
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
High-density lipoprotein subclasses and apolipoprotein A-I
1999
Effects of statins on stroke prevention in patients with and without coronary heart disease: A meta-analysis of randomized controlled trials
2004
Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease
2004
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Atherosclerosis
2000 StandoutNature
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
2008 Standout
Modulation of paraoxonase (PON1) activity
2004
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
2011 Standout
Matrix metalloproteinases A review of their structure and role in acute coronary syndrome
2003
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women
2000 Standout
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
2004 Standout
HDL therapy for the acute treatment of atherosclerosis
2002
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
2010 StandoutNature
Mevalonate pathway: A review of clinical and therapeutical implications
2007
Inhibition of VCAM-1 Expression in Endothelial Cells by Reconstituted High Density Lipoproteins
1997
Endothelial Activation by aPL: A Potential Pathogenetic Mechanism for the Clinical Manifestations of the Syndrome
2000
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
2006 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
2005 Standout
Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes
2003
Role of apoptosis in atherosclerosis and its therapeutic implications
2004
Extracellular vesicles: Exosomes, microvesicles, and friends
2013 Standout
RhoC GTPase Expression as a Potential Marker of Lymph Node Metastasis in Squamous Cell Carcinomas of the Head and Neck
2006
Markers of Inflammation and Cardiovascular Disease
2003 Standout
The Ability to Promote Efflux Via ABCA1 Determines the Capacity of Serum Specimens With Similar High-Density Lipoprotein Cholesterol to Remove Cholesterol From Macrophages
2010
Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly.
2002 Standout
Pleiotropic Effects of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors
2001
Low Levels of Extrahepatic Nonmacrophage ApoE Inhibit Atherosclerosis Without Correcting Hypercholesterolemia in ApoE-Deficient Mice
2000
Hypertriglyceridemia in the Genomic Era: A New Paradigm
2015
5 Oestrogens and atherosclerotic vascular disease—lipid factors
1993
High-Density Lipoproteins Induce Transforming Growth Factor-β 2 Expression in Endothelial Cells
2005
Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein
1999
Lysophosphatidylcholine Promotes Cholesterol Efflux From Mouse Macrophage Foam Cells
1997
ACAT2 Is Localized to Hepatocytes and Is the Major Cholesterol-Esterifying Enzyme in Human Liver
2004 StandoutNobel
Inflammation and Atherosclerosis
2002 Standout
An HMG-CoA Reductase Inhibitor, Cerivastatin, Suppresses Growth of Macrophages Expressing Matrix Metalloproteinases and Tissue Factor In Vivo and In Vitro
2001
Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women
1995 Standout
Fluorescent Sensors for Measuring Metal Ions in Living Systems
2014 Standout
Design and Baseline Characteristics of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study
2003
Potential Role of Endotoxin as a Proinflammatory Mediator of Atherosclerosis
2004
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Cardiovascular Status of Carriers of the Apolipoprotein A-I Milano Mutant
2001
Small high density lipoprotein subclasses: some of their physico-chemical properties and stability in solution.
2005
Applications of Palladium-Catalyzed C–N Cross-Coupling Reactions
2016 Standout
High-Density Lipoprotein Restores Endothelial Function in Hypercholesterolemic Men
2002
2-Amino-3-(phenylsulfanyl)norbornane-2-carboxylate: An Appealing Scaffold for the Design of Rac1–Tiam1 Protein–Protein Interaction Inhibitors
2014
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
2001 Standout
Statin Therapy in Acute Coronary Syndromes
2002
High-Dose Atorvastatin after Stroke or Transient Ischemic Attack
2006 Standout
Treatment of Periodontitis and Endothelial Function
2007 Standout
Works of Franco Bernini being referenced
Direct vascular effects of HMG-CoA reductase inhibitors
1998
Natural Anti-endothelial Cell Antibodies (AECA)
1999
Non-lipid-related effects of statins
2000
The molecular structure of apolipoprotein A-II modulates the capacity of HDL to promote cell cholesterol efflux
1996
Pathogenesis of atherosclerosisand the role of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors
1995
Oxidized LDL increase free cholesterol and fail to stimulate cholesterol esterification in murine macrophages
1990
Functional LCAT is not required for macrophage cholesterol efflux to human serum
2008
Progesterone modulates the expression of HDL binding sites in human skin fibroblasts
1988
An ω-3 polyunsaturated fatty acid concentrate increases plasma high-density lipoprotein 2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia
2004
Cholesterol Efflux and Reverse Cholesterol Transport
2014
Low-dose expression of a human apolipoprotein E transgene in macrophages restores cholesterol efflux capacity of apolipoprotein E-deficient mouse plasma
1998
HMG-CoA Reductase Inhibitors Reduce MMP-9 Secretion by Macrophages
1998
Defective catabolism of oxidized LDL by J774 murine macrophages.
1992
Pleiotropic effects of statins in atherosclerosis and diabetes.
2000
Increased synthesis of plasminogen activator inhibitor-1 by cultured human endothelial cells exposed to native and modified LDLs. An LDL receptor-independent phenomenon.
1993
Human Apolipoproteins A-I and A-II in Cell Cholesterol Efflux
1998
Cell Cholesterol Efflux to Reconstituted High-Density Lipoproteins Containing the Apolipoprotein A-IMilano Dimer
1999
Characterization of Three Kindreds With Familial Combined Hypolipidemia Caused by Loss-of-Function Mutations of ANGPTL3
2011
HMG-CoA Reductase Inhibitors Reduce Acetyl LDL Endocytosis in Mouse Peritoneal Macrophages
1995
Reduced triglyceridemia and increased high density lipoprotein cholesterol levels after treatment with acipimox, anew inhibitor of lipolysis
1981
Probucol Inhibits ABCA1-Mediated Cellular Lipid Efflux
2004
Increased Cholesterol Efflux Potential of Sera From ApoA-I Milano Carriers and Transgenic Mice
1999
Effect of L-propranolol on the binding, internalization and degradation of 125I-low density lipoproteins by human skin fibroblasts
1981